Theriva Biologics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
Theriva Biologics, Inc. (TOVX) had Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 22.00 thousand shares as of 2023-05-10, per its 10-K filed 2024-03-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2024-03-25
- 2023-05-10: Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 22.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number |
|---|---|
| 2023-05-10 | 22.00K shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |